BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 10630195)

  • 21. Reversal of pathology in murine mucopolysaccharidosis type VII by somatic cell gene transfer.
    Wolfe JH; Sands MS; Barker JE; Gwynn B; Rowe LB; Vogler CA; Birkenmeier EH
    Nature; 1992 Dec 24-31; 360(6406):749-53. PubMed ID: 1465145
    [TBL] [Abstract][Full Text] [Related]  

  • 22. High level expression and export of beta-glucuronidase from murine mucopolysaccharidosis VII cells corrected by a double-copy retrovirus vector.
    Wolfe JH; Kyle JW; Sands MS; Sly WS; Markowitz DG; Parente MK
    Gene Ther; 1995 Jan; 2(1):70-8. PubMed ID: 7712336
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Widespread correction of lysosomal storage following intrahepatic injection of a recombinant adeno-associated virus in the adult MPS VII mouse.
    Sferra TJ; Backstrom K; Wang C; Rennard R; Miller M; Hu Y
    Mol Ther; 2004 Sep; 10(3):478-91. PubMed ID: 15336648
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Histopathological and behavioral improvement of murine mucopolysaccharidosis type VII by intracerebral transplantation of neural stem cells.
    Fukuhara Y; Li XK; Kitazawa Y; Inagaki M; Matsuoka K; Kosuga M; Kosaki R; Shimazaki T; Endo H; Umezawa A; Okano H; Takahashi T; Okuyama T
    Mol Ther; 2006 Mar; 13(3):548-55. PubMed ID: 16316785
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Correction of lysosomal storage in the liver and spleen of MPS VII mice by implantation of genetically modified skin fibroblasts.
    Moullier P; Bohl D; Heard JM; Danos O
    Nat Genet; 1993 Jun; 4(2):154-9. PubMed ID: 8348154
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Neural progenitor cell engraftment corrects lysosomal storage throughout the MPS VII mouse brain.
    Snyder EY; Taylor RM; Wolfe JH
    Nature; 1995 Mar; 374(6520):367-70. PubMed ID: 7885477
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Gene transfer of low levels of beta-glucuronidase corrects hepatic lysosomal storage in a large animal model of mucopolysaccharidosis VII.
    Wolfe JH; Sands MS; Harel N; Weil MA; Parente MK; Polesky AC; Reilly JJ; Hasson C; Weimelt S; Haskins ME
    Mol Ther; 2000 Dec; 2(6):552-61. PubMed ID: 11124056
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Widespread correction of lysosomal storage in the mucopolysaccharidosis type VII mouse brain with a herpes simplex virus type 1 vector expressing beta-glucuronidase.
    Berges BK; Yellayi S; Karolewski BA; Miselis RR; Wolfe JH; Fraser NW
    Mol Ther; 2006 May; 13(5):859-69. PubMed ID: 16515890
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Elimination of lysosomal storage in brains of MPS VII mice treated by intrathecal administration of an adeno-associated virus vector.
    Elliger SS; Elliger CA; Aguilar CP; Raju NR; Watson GL
    Gene Ther; 1999 Jun; 6(6):1175-8. PubMed ID: 10455422
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Long-term expression of beta-glucuronidase by genetically modified human neural progenitor cells grafted into the mouse central nervous system.
    Buchet D; Serguera C; Zennou V; Charneau P; Mallet J
    Mol Cell Neurosci; 2002 Mar; 19(3):389-401. PubMed ID: 11906211
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Adenovirus-mediated gene therapy for corneal clouding in mice with mucopolysaccharidosis type VII.
    Kamata Y; Okuyama T; Kosuga M; O'hira A; Kanaji A; Sasaki K; Yamada M; Azuma N
    Mol Ther; 2001 Oct; 4(4):307-12. PubMed ID: 11592832
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Widespread distribution of adenovirus-transduced monkey amniotic epithelial cells after local intracerebral injection: implication for cell-mediated therapy for lysosome storage disorders.
    Kosuga M; Takahashi S; Tanabe A; Fujino M; Li XK; Suzuki S; Yamada M; Kakishita K; Ono F; Sakuragawa N; Okuyama T
    Cell Transplant; 2001; 10(4-5):435-9. PubMed ID: 11549068
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Somatic gene therapy for a neurodegenerative disease using microencapsulated recombinant cells.
    Ross CJ; Ralph M; Chang PL
    Exp Neurol; 2000 Dec; 166(2):276-86. PubMed ID: 11085893
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Enzyme replacement with recombinant beta-glucuronidase in murine mucopolysaccharidosis type VII: impact of therapy during the first six weeks of life on subsequent lysosomal storage, growth, and survival.
    Vogler C; Sands MS; Levy B; Galvin N; Birkenmeier EH; Sly WS
    Pediatr Res; 1996 Jun; 39(6):1050-4. PubMed ID: 8725268
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A TAT-modified fusion protein efficiently penetrates mouse hypoglossal nuclei from transduced ependyma.
    Alisky JM; Xia H; Davidson BL
    Neurosci Lett; 2006 Jun; 401(1-2):40-3. PubMed ID: 16650576
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The HIV Tat protein transduction domain improves the biodistribution of beta-glucuronidase expressed from recombinant viral vectors.
    Xia H; Mao Q; Davidson BL
    Nat Biotechnol; 2001 Jul; 19(7):640-4. PubMed ID: 11433275
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Murine mucopolysaccharidosis type VII: the impact of therapies on the clinical course and pathology in a murine model of lysosomal storage disease.
    Vogler C; Sands MS; Galvin N; Levy B; Thorpe C; Barker J; Sly WS
    J Inherit Metab Dis; 1998 Aug; 21(5):575-86. PubMed ID: 9728337
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cloning of the canine beta-glucuronidase cDNA, mutation identification in canine MPS VII, and retroviral vector-mediated correction of MPS VII cells.
    Ray J; Bouvet A; DeSanto C; Fyfe JC; Xu D; Wolfe JH; Aguirre GD; Patterson DF; Haskins ME; Henthorn PS
    Genomics; 1998 Mar; 48(2):248-53. PubMed ID: 9521879
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Neonatal intramuscular injection with recombinant adeno-associated virus results in prolonged beta-glucuronidase expression in situ and correction of liver pathology in mucopolysaccharidosis type VII mice.
    Daly TM; Okuyama T; Vogler C; Haskins ME; Muzyczka N; Sands MS
    Hum Gene Ther; 1999 Jan; 10(1):85-94. PubMed ID: 10022533
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Adenovirus-mediated gene therapy for mucopolysaccharidosis VII: involvement of cross-correction in wide-spread distribution of the gene products and long-term effects of CTLA-4Ig coexpression.
    Kosuga M; Takahashi S; Sasaki K; Li XK; Fujino M; Hamada H; Suzuki S; Yamada M; Matsuo N; Okuyama T
    Mol Ther; 2000 May; 1(5 Pt 1):406-13. PubMed ID: 10933961
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.